Ningbo Sinova I/E Corp. established in 2006, is engaged in the field of APIs, intermediates and fine chemicals for international markets, as well as by adopting new process / production development to follow our customers’ special requirements. Our main products are Dapagliflozin, Empagliflozin ,Canagliflozin,Rosuvastatin Calcium,Atorvastatin Calcium,Alogliptin Benzoate,Cilostazol,Dorzolamide,Azelastine, Granisetron, Ttrimebutine, Candesartan,Simvastatin ,Sitagliptin,Vildagliptin, Benfotiamine ,UDCA, GHYH and related intermediates.
more >
Year of Establishment:
2006
Total Assets(USD):
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Agent,Trading Company,Manufacturer
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: